• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

匹莫范色林作为5-HT2A受体PET放射性配体的¹¹C标记及初步评估

(11)C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand.

作者信息

Andersen Valdemar L, Hansen Hanne D, Herth Matthias M, Dyssegaard Agnete, Knudsen Gitte M, Kristensen Jesper L

机构信息

Neurobiology Research Unit, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark; Center for Integrated Molecular Brain Imaging, University of Copenhagen Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.

Neurobiology Research Unit, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark; Center for Integrated Molecular Brain Imaging, University of Copenhagen Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.

出版信息

Bioorg Med Chem Lett. 2015 Mar 1;25(5):1053-6. doi: 10.1016/j.bmcl.2015.01.017. Epub 2015 Jan 20.

DOI:10.1016/j.bmcl.2015.01.017
PMID:25655720
Abstract

Pimavanserin is a selective serotonin 2A receptor (5-HT2AR) inverse agonist that has shown promise for treatment of psychotic symptoms in patients with Parkinson's disease. Here, we detail the (11)C-labeling and subsequently evaluate pimavanserin as a PET-radioligand in pigs. [(11)C]Pimavanserin was obtained by N-methylation of an appropriate precursor using [(11)C]MeOTf in acetone at 60°C giving radiochemical yields in the range of 1-1.7GBq (n=4). In Danish Landrace pigs the radio ligand readily entered the brain and displayed binding in the cortex in accordance with the distribution of 5-HT2ARs. However, this binding could not be blocked by either ketanserin or pimavanserin itself, indicating high nonspecific binding. The lack of displacement by the 5-HT2R antagonist and binding in the thalamus suggests that [(11)C]pimavanserin is not selective for the 5-HT2AR in pigs.

摘要

匹莫范色林是一种选择性5-羟色胺2A受体(5-HT2AR)反向激动剂,已显示出治疗帕金森病患者精神症状的潜力。在此,我们详细介绍了[11C]标记过程,并随后在猪身上评估了匹莫范色林作为正电子发射断层扫描(PET)放射性配体的情况。[11C]匹莫范色林是通过在60°C的丙酮中使用[11C]三氟甲磺酸甲酯([11C]MeOTf)对合适的前体进行N-甲基化得到的,放射化学产率在1 - 1.7GBq范围内(n = 4)。在丹麦长白猪中,该放射性配体很容易进入大脑,并根据5-HT2AR的分布在皮质中显示出结合。然而,这种结合不能被酮色林或匹莫范色林本身阻断,表明存在高非特异性结合。5-HT2R拮抗剂不能使其发生置换以及在丘脑的结合情况表明,[11C]匹莫范色林在猪体内对5-HT2AR没有选择性。

相似文献

1
(11)C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand.匹莫范色林作为5-HT2A受体PET放射性配体的¹¹C标记及初步评估
Bioorg Med Chem Lett. 2015 Mar 1;25(5):1053-6. doi: 10.1016/j.bmcl.2015.01.017. Epub 2015 Jan 20.
2
Pimavanserin exhibits serotonin 5-HT receptor inverse agonism for G- and neutral antagonism for G-proteins in human brain cortex.匹伐沙胺在人大脑皮质中表现出 5-羟色胺 5-HT 受体的反向激动作用,对 G 蛋白呈中性拮抗作用。
Eur Neuropsychopharmacol. 2020 Jul;36:83-89. doi: 10.1016/j.euroneuro.2020.05.004. Epub 2020 Jun 7.
3
Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.(18)F标记的5-HT2A受体激动剂作为正电子发射断层显像(PET)配体的合成与评价
Nucl Med Biol. 2016 Aug;43(8):455-62. doi: 10.1016/j.nucmedbio.2016.02.011. Epub 2016 Apr 19.
4
Cerebral 5-HT release correlates with [C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain.大脑5-羟色胺释放与猪脑中5-羟色胺2A受体占有率的[C]Cimbi36正电子发射断层扫描测量结果相关。
J Cereb Blood Flow Metab. 2017 Feb;37(2):425-434. doi: 10.1177/0271678X16629483. Epub 2016 Jul 20.
5
Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.11C-CIMBI-5 的放射性合成与评价:一种用于 PET 的 5-HT2A 受体激动剂放射性配体。
J Nucl Med. 2010 Nov;51(11):1763-70. doi: 10.2967/jnumed.109.074021. Epub 2010 Oct 18.
6
Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: Pimavanserin.帕金森病伴发精神病的治疗选择:重点介绍新批准药物——匹莫范色林。
CNS Neurol Disord Drug Targets. 2017;16(3):234-243. doi: 10.2174/1871527315666161006104347.
7
Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.一系列取代的 11C-苯乙胺作为 5-HT(2A)激动剂 PET 示踪剂的放射性合成和体内评价。
Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):681-93. doi: 10.1007/s00259-010-1686-8. Epub 2010 Dec 21.
8
Convergent F-labeling and evaluation of N-benzyl-phenethylamines as 5-HT receptor PET ligands.作为5-羟色胺受体PET配体的N-苄基苯乙胺的收敛性F标记与评估
Bioorg Med Chem. 2016 Nov 1;24(21):5353-5356. doi: 10.1016/j.bmc.2016.08.056. Epub 2016 Aug 29.
9
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.睡眠瘫痪性幻觉的神经药理学:血清素 2A 激活和一种新的治疗药物。
Psychopharmacology (Berl). 2018 Nov;235(11):3083-3091. doi: 10.1007/s00213-018-5042-1. Epub 2018 Oct 5.
10
Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.[(11)C]Cimbi-36作为非人类灵长类动物大脑中5-HT(2A)和5-HT(2C)受体激动剂PET放射性配体的表征
Neuroimage. 2014 Jan 1;84:342-53. doi: 10.1016/j.neuroimage.2013.08.035. Epub 2013 Aug 28.

引用本文的文献

1
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia: Results From the Phase 2 ADVANCE Study.精神分裂症患者中 pimavanserin 的暴露-反应分析:来自 2 期 ADVANCE 研究的结果。
J Clin Psychopharmacol. 2022;42(6):544-551. doi: 10.1097/JCP.0000000000001611. Epub 2022 Oct 3.
2
"Selective" serotonin 5-HT receptor antagonists.“选择性”血清素 5-HT 受体拮抗剂。
Biochem Pharmacol. 2022 Jun;200:115028. doi: 10.1016/j.bcp.2022.115028. Epub 2022 Apr 4.
3
An Pig Model for Testing Novel Positron Emission Tomography Radioligands Targeting Cerebral Protein Aggregates.
一种用于测试靶向脑蛋白聚集体的新型正电子发射断层扫描放射性配体的猪模型。
Front Neurosci. 2022 Mar 16;16:847074. doi: 10.3389/fnins.2022.847074. eCollection 2022.
4
Blocking of efflux transporters in rats improves translational validation of brain radioligands.阻断大鼠体内的外排转运体可改善脑放射性配体的转化验证。
EJNMMI Res. 2020 Oct 19;10(1):124. doi: 10.1186/s13550-020-00718-x.
5
Cerebral serotonin release correlates with [C]AZ10419369 PET measures of 5-HT receptor binding in the pig brain.大脑中血清素的释放与猪脑 5-HT 受体结合的 [C]AZ10419369 PET 测量结果相关。
J Cereb Blood Flow Metab. 2018 Jul;38(7):1243-1252. doi: 10.1177/0271678X17719390. Epub 2017 Jul 7.
6
Cerebral 5-HT release correlates with [C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain.大脑5-羟色胺释放与猪脑中5-羟色胺2A受体占有率的[C]Cimbi36正电子发射断层扫描测量结果相关。
J Cereb Blood Flow Metab. 2017 Feb;37(2):425-434. doi: 10.1177/0271678X16629483. Epub 2016 Jul 20.